BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15147500)

  • 21. Physiology of somatostatin receptors.
    Guillermet-Guibert J; Lahlou H; Cordelier P; Bousquet C; Pyronnet S; Susini C
    J Endocrinol Invest; 2005; 28(11 Suppl International):5-9. PubMed ID: 16625838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina?
    Thermos K; Bagnoli P; Epelbaum J; Hoyer D
    Pharmacol Ther; 2006 Jun; 110(3):455-64. PubMed ID: 16274747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular trafficking of somatostatin receptors.
    Jacobs S; Schulz S
    Mol Cell Endocrinol; 2008 May; 286(1-2):58-62. PubMed ID: 18045773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function and expression of somatostatin receptors of the endocrine pancreas.
    Strowski MZ; Blake AD
    Mol Cell Endocrinol; 2008 May; 286(1-2):169-79. PubMed ID: 18375050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nerve tissue distribution and physiologic role of somatostatin and its receptor].
    Shimizu N; Tanaka K; Ito S
    Nihon Rinsho; 1990 May; 48(5):1037-41. PubMed ID: 1973950
    [No Abstract]   [Full Text] [Related]  

  • 26. Biology of somatostatin in breast cancer.
    Watt HL; Kharmate G; Kumar U
    Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The A3 adenosine receptor: an enigmatic player in cell biology.
    Gessi S; Merighi S; Varani K; Leung E; Mac Lennan S; Borea PA
    Pharmacol Ther; 2008 Jan; 117(1):123-40. PubMed ID: 18029023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin, cortistatin, ghrelin and glucose metabolism.
    Gauna C; van der Lely AJ
    J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides.
    Webb CK; McCudden CR; Willard FS; Kimple RJ; Siderovski DP; Oxford GS
    J Neurochem; 2005 Mar; 92(6):1408-18. PubMed ID: 15748159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
    Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
    J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
    Watt HL; Kharmate GD; Kumar U
    Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily.
    Wu H
    Adv Protein Chem; 2004; 68():225-79. PubMed ID: 15500863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
    de Bruin C; Feelders RA; Waaijers AM; van Koetsveld PM; Sprij-Mooij DM; Lamberts SW; Hofland LJ
    J Mol Endocrinol; 2009 Jan; 42(1):47-56. PubMed ID: 18852217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System.
    Shamsi BH; Chatoo M; Xu XK; Xu X; Chen XQ
    Front Endocrinol (Lausanne); 2021; 12():652363. PubMed ID: 33796080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in understanding neuronal somatostatin receptors.
    Selmer I; Schindler M; Allen JP; Humphrey PP; Emson PC
    Regul Pept; 2000 Jun; 90(1-3):1-18. PubMed ID: 10828487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin receptors in humans: biological role and clinical relevance.
    Ekmekcioglu C
    Biomed Pharmacother; 2006 Apr; 60(3):97-108. PubMed ID: 16527442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscarinic receptor subtypes in the alimentary tract.
    Tobin G; Giglio D; Lundgren O
    J Physiol Pharmacol; 2009 Mar; 60(1):3-21. PubMed ID: 19439804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal-transduction pathways that regulate smooth muscle function. II. Receptor-ion channel coupling mechanisms in gastrointestinal smooth muscle.
    Akbarali HI
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G598-602. PubMed ID: 15764809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic but not acute intracerebroventricular administration of amyloid beta-peptide(25-35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity, and adenylate cyclase I levels in the rat hippocampus.
    Burgos-Ramos E; Hervás-Aguilar A; Puebla-Jiménez L; Boyano-Adánez MC; Arilla-Ferreiro E
    J Neurosci Res; 2007 Feb; 85(2):433-42. PubMed ID: 17086550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling.
    Somvanshi RK; Billova S; Kharmate G; Rajput PS; Kumar U
    Cell Signal; 2009 Sep; 21(9):1396-414. PubMed ID: 19426801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.